LYMPHATIC MAPPING

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting LYMPHATIC MAPPING:

# Drug Count
0 AMANTADINE 1
1 BACLOFEN 1
2 DABRAFENIB 1
3 DENOSUMAB 1
4 DOXAZOSIN 1
5 DOXAZOSIN MESYLATE 1
6 ESCITALOPRAM 1
7 ESCITALOPRAM OXALATE 1
8 ESCITSLOPRAM 1
9 FINGOLIMOD HCL 1
See all common drugs associated with LYMPHATIC MAPPING

LYMPHATIC MAPPING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHYLENE BLUE 1 0.0006
1 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 1 0.0002
2 AMANTADINE 1 0.0001
3 DABRAFENIB 1 0.0000
4 TRAMETINIB 1 0.0000
5 MODAFINIL 1 0.0000
6 DOXAZOSIN MESYLATE 1 0.0000
7 LEUPROLIDE ACETATE 1 0.0000
8 FINGOLIMOD HCL 1 0.0000
9 BACLOFEN 1 0.0000
See all drugs enriched for association with LYMPHATIC MAPPING

These drug classes are most commonly taken by patients reporting LYMPHATIC MAPPING:

# Drug class Count
0 Corticosteroid [EPC] 1
1 RANK Ligand Inhibitor [EPC] 1
2 Sympathomimetic-like Agent [EPC] 1
3 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
See all common drug classes associated with LYMPHATIC MAPPING

LYMPHATIC MAPPING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sympathomimetic-like Agent [EPC] 1 0.0000
1 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
2 RANK Ligand Inhibitor [EPC] 1 0.0000
3 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with LYMPHATIC MAPPING